AzTrials
AzTrials

Atlantoaxial DislocationNCT06003491

Trial for Surgical Treatment of Reducible Atlantoaxial Dislocation

A study testing Intra-articular Cages in people with Atlantoaxial Dislocation, run by Xuanwu Hospital, Beijing at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The management of reducible atlantoaxial dislocation associated is challenging. Direct posterior distraction technique we proposed in 2010 could achieve satisfactory reduction. In 2020, we modified this technique and proposed a posterior intra-articular distraction technique. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Atlantoaxial Dislocation
What is being tested?
Intra-articular Cages
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
164 participants
Where
1 siteChina
Study dates
29 Jul 2024to Feb 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • CT indicated atlantoaxial dislocation Agree with the operation plan Agree to be followed up

Who cannot join

  • The pathology is traumatic or RA Underwent operations in occipital-cervical region before With mortal diseases Without ability to sign papers

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Xuanwu Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100032

    zan chen, PHD, MD, +86 13911712120, chenzan66@163.com

    Recruiting

Other trials in China

About this study

Official title: A Randomized Controlled Trial for Surgical Treatment of Reducible Atlantoaxial Dislocation

The management of reducible atlantoaxial dislocation associated is challenging. Direct posterior distraction technique we proposed in 2010 could achieve satisfactory reduction. In 2020, we modified this technique and proposed a posterior intra-articular distraction technique. The intra-articular distraction technique could theoretically achieve satisfactory reduction and fusion. However, its superiority has not been proven. Therefore, we design a RCT study to compare the reduction rate and fusion rate of different strategies.

Being tested
Intra-articular Cages

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intra-articular CagesDevice

    Using reduction using posterior intra-articular distraction and fusion technique with cages.

Study groups in NCT06003491
Study groupRoleWhat they receive
Intra-articular GroupExperimentalPosterior intra-articular distraction and fusion
Receives: Device: Intra-articular Cages
Posterior GroupNo interventionPosterior direct distraction and fusion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fusion Rates

    Atlantoaixal fusion rates

    Measured: 12 months

Secondary outcomes (3)
  1. Japanese Orthopaedic Association Scores

    0-17 Scores

    Measured: 12 months

  2. Visual Analogue Scale

    0-10 Scores

    Measured: 12 months

  3. Neck Disability Index

    0-5 Scores

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2023
  2. Study start29 Jul 2024
  3. Primary completionFeb 2028 (estimated)
  4. Study completionFeb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
164 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06003491
Sponsor's protocol ID
XW-NS-RCTRAAD
Status last verified
Oct 2026
First submitted
30 Jul 2023
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chen Z, Duan W, Chou D, Guan J, Liu Z, Jian Q, Zhang B, Bo X, Jian F. A Safe and Effective Posterior Intra-Articular Distraction Technique to Treat Congenital Atlantoaxial Dislocation Associated With Basilar Invagination: Case Series and Technical Nuances. Oper Neurosurg. 2021 Mar 15;20(4):334-342. doi: 10.1093/ons/opaa391.

    PubMed 33372978

Questions about this trial

What is this clinical trial studying?

A study testing Intra-articular Cages in people with Atlantoaxial Dislocation, run by Xuanwu Hospital, Beijing at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zan Chen, MD (+8613911712120, chenzan66@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fusion Rates (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06003491, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in